Tuesday, August 11, 2026

Novo Nordisk Pushes for First Oral Obesity Drug Approval

Novo Nordisk seeks FDA approval for oral Wegovy, potentially the first oral obesity treatment, amid competition with Eli Lilly.

Putin Sends Warm Wishes to Kim, Celebrates 77 Years of North Korea-Russia Ties

Putin reaffirms strong North Korea-Russia ties in a message to Kim Jong-un following their summit, highlighting diplomatic relations.

Blood Test Alone May Predict Chemotherapy Response and Prognosis in Lymphoma Patients

South Korean researchers discover a mechanism reducing rituximab's effectiveness in DLBCL and propose a predictive blood biomarker.

Tag: CNS diseases

SK Biopharm CEO Lee Dong-hoon: “AI and open innovation are key to drug development” [BIO USA]

SK Biopharmaceuticals focuses on open innovation and AI for drug development, aiming to enhance CNS therapies and expand into new modalities.

Top News

- Our Sponsors Ad -

Follow us